Randomized controlled trial of colchicine add on to the standard therapy in moderate and severe corona virus Disease-19 infection

BACKGROUND: COVID19 complications cause inflammatory storm. Colchicine is a potent anti-inflammatory medication that has been proposed as a possible treatment option for COVID-19. OBJECTIVE: to assess effectiveness and safety of add on use of colchicine to the standard treatment in moderate and seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorial, Faiq I., Maulood, Mohammed Fauzi, Abdulamir, Ahmed S., Alnuaimi, Ahmed Sameer, abdulrrazaq, Manal K., Bonyan, Fadil Agla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Randomised Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994704/
https://www.ncbi.nlm.nih.gov/pubmed/35432984
http://dx.doi.org/10.1016/j.amsu.2022.103593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994704/
https://www.ncbi.nlm.nih.gov/pubmed/35432984
http://dx.doi.org/10.1016/j.amsu.2022.103593

Ejemplares similares